Table 2.
Differences in Primary and Secondary Outcomes
| Outcome | Effect Size, h | 95% Confidence Interval |
|---|---|---|
| n = 117 | ||
| Mean length of stay (B period) | 494.7 | 275.1 to 714.4 |
| Average treatment effect (Δ TTD) | –250.4 | –491.9 to –8.8 |
| n = 95 (only includes patients with TTD ≤18 d) | ||
| Mean length of stay (B period) | 149.6 | 121.7 to 177.5 |
| Average treatment effect (Δ TTD + age + sex) | –38.6 | –83.6 to 6.5 |
| (Δ TTD + age + sex + TTDAT) | –37.2 | –82.0 to 7.6 |
| (Δ TTD + age + sex + TTMR) | Model doesn’t converge | |
| n = 117 | ||
| Mean time to final microbiology reporting | 56.4 | 32.7 to 80.2 |
| (Δ TTMR) | –28.7 | –55.1 to –2.4 |
| n = 95 (only includes patients with TTD ≤18 d) | ||
| Mean time to final microbiology reporting | 62.9 | 34.1 to 91.8 |
| (Δ TTMR) | –33.8 | –67.1 to –0.5 |
Abbreviations: TTD, time to hospital discharge; TTMR, time to final microbiology reporting.